knowledge -WSS

knowledge

author：comprehensive 2025-09-05 09:17:57 - browse：1

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medical devices makers are asking for forgiveness, not permission

Wikipedia

WSS

Medical devices makers are asking for forgiveness, not permission

Testing GLP

CRISPR technology availability, affordability needs to be expanded

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Surgeons perform first xenotransplant using CRISPR'd pig kidney

hotspot

knowledge

Wikipedia

At least 13 dead in Texas as scorching temps continue

Testing for cancer recurrence creates a new limbo for patients

The cancer drug shortage isn’t new — and neither are the solutions

U.K. officials, researchers try to ease path for bespoke genetic treatments

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Traditional Chinese medicine benefits explored in new JAMA study

Supreme Court strikes down use of affirmative action

Asbestos ban is immediate, but health effects will linger for decades

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Senate panel to vote on hospitals, PBMs, prisoner care

knowledge

Diabetes management: Digital health tools fall short, study says

Diabetes management: Digital health tools fall short, study says

Telehealth options flood the market as retailers push virtual care

Physician subsidies by hospitals soar in wake of No Surprises Act

Cancer, immunology, HIV research ensnared in fetal tissue politics

What Kate Middleton's cancer revelation might teach the world

focus

explore

Wikipedia

explore